Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
China
Enrollment target
~82 participants
Started
May 2026
Primary completion
May 2028
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xianmin Song, PhD
Shanghai General Hospital Affiliated to Shanghai Jiao Tong University